Venture Visionary Partners LLC acquired a new stake in shares of C3.ai, Inc. (NYSE:AI - Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 25,325 shares of the company's stock, valued at approximately $533,000.
A number of other large investors have also added to or reduced their stakes in the stock. Russell Investments Group Ltd. raised its stake in C3.ai by 100.7% during the fourth quarter. Russell Investments Group Ltd. now owns 909 shares of the company's stock valued at $31,000 after buying an additional 456 shares during the last quarter. PNC Financial Services Group Inc. raised its stake in shares of C3.ai by 8.4% in the first quarter. PNC Financial Services Group Inc. now owns 6,546 shares of the company's stock worth $138,000 after purchasing an additional 510 shares during the last quarter. Optimum Investment Advisors raised its stake in shares of C3.ai by 35.6% in the first quarter. Optimum Investment Advisors now owns 2,668 shares of the company's stock worth $56,000 after purchasing an additional 700 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. raised its stake in shares of C3.ai by 2.0% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 35,460 shares of the company's stock worth $773,000 after purchasing an additional 708 shares during the last quarter. Finally, Probity Advisors Inc. raised its stake in shares of C3.ai by 4.4% in the first quarter. Probity Advisors Inc. now owns 17,444 shares of the company's stock worth $367,000 after purchasing an additional 738 shares during the last quarter. Hedge funds and other institutional investors own 38.96% of the company's stock.
Wall Street Analyst Weigh In
AI has been the subject of several recent analyst reports. Morgan Stanley boosted their price target on C3.ai from $20.00 to $22.00 and gave the stock an "underweight" rating in a research note on Thursday, May 29th. Needham & Company LLC restated a "hold" rating on shares of C3.ai in a research note on Monday, August 11th. KeyCorp restated a "mixed" rating on shares of C3.ai in a research note on Thursday, May 29th. Westpark Capital upgraded C3.ai to a "strong-buy" rating and set a $40.00 price target for the company in a research note on Wednesday, July 9th. Finally, UBS Group cut their price objective on C3.ai from $28.00 to $27.00 and set a "neutral" rating for the company in a report on Thursday, June 26th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, eight have given a Hold rating and five have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Reduce" and a consensus price target of $27.43.
Read Our Latest Stock Analysis on C3.ai
C3.ai Stock Performance
NYSE:AI opened at $16.9150 on Thursday. The stock has a 50-day simple moving average of $23.99 and a two-hundred day simple moving average of $24.02. C3.ai, Inc. has a 52-week low of $14.70 and a 52-week high of $45.08. The firm has a market capitalization of $2.27 billion, a PE ratio of -7.55 and a beta of 1.98.
C3.ai (NYSE:AI - Get Free Report) last released its quarterly earnings results on Wednesday, May 28th. The company reported ($0.16) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.20) by $0.04. C3.ai had a negative return on equity of 33.51% and a negative net margin of 74.21%.The business had revenue of $108.72 million during the quarter, compared to analyst estimates of $107.85 million. During the same quarter in the previous year, the company posted ($0.11) earnings per share. C3.ai's revenue for the quarter was up 25.5% on a year-over-year basis. C3.ai has set its Q1 2026 guidance at EPS. FY 2026 guidance at EPS. Equities analysts forecast that C3.ai, Inc. will post -2.44 earnings per share for the current fiscal year.
Insider Buying and Selling
In other C3.ai news, VP Merel Witteveen sold 5,485 shares of the business's stock in a transaction dated Monday, June 16th. The stock was sold at an average price of $23.95, for a total transaction of $131,365.75. Following the completion of the sale, the vice president owned 13,740 shares of the company's stock, valued at approximately $329,073. The trade was a 28.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Thomas M. Siebel sold 577,678 shares of the company's stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $16.78, for a total value of $9,693,436.84. Following the completion of the transaction, the chief executive officer directly owned 2,973,572 shares of the company's stock, valued at approximately $49,896,538.16. This trade represents a 16.27% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 2,257,074 shares of company stock worth $53,260,950. Company insiders own 33.54% of the company's stock.
About C3.ai
(
Free Report)
C3.ai, Inc operates as an enterprise artificial intelligence (AI) software company in North America, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides C3 AI platform, an application development and runtime environment that enables customers to design, develop, and deploy enterprise AI applications; C3 AI Ex Machina for analysis-ready data; C3 AI CRM, an industry specific customer relationship management solution; and C3 Generative AI Product Suite that enables to locate, retrieve, and present information.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider C3.ai, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and C3.ai wasn't on the list.
While C3.ai currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.